Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Older Adults
Key facts
- Who runs it
- Tor Biering-Sørensen
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 881,373 people enrolled
- Started
- 14 Sept 2023
- Ended
- 31 May 2024
- Type of study
- Interventional, 7 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Behavioral Economic Principles
- Record updated
- 10 October 2024
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Age >=65 years at January 15, 2024 (eligible for free-of-charge influenza vaccination in the Danish public health system)
- Access to the official, mandatory Danish electronic mailbox system
Who cannot take part
- Persons living in nursing homes (approximated as any person living at an address with >=6 inhabitants aged 80 years and above)
- Known to have already scheduled influenza vaccination appointment
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In randomized clinical trials and observational studies, influenza vaccination has been shown to be effective in reducing influenza-related illness, hospitalizations, cardiovascular events, and mortality in select populations. However, the real-world effectiveness of influenza vaccination is limited by its uptake. Conducted during the 2022/2023 influenza season, the first NUDGE-FLU trial demonstrated the effectiveness of two electronic behavioral nudging letter strategies in increasing influenza vaccination rates among older adults in Denmark - a letter highlighting potential cardiovascular benefits of vaccination and a standard informational letter sent at baseline and repeated at day 14. This present study will once again investigate whether digital behavioral nudges delivered via the official, mandatory Danish electronic letter system can increase influenza vaccine uptake among older adults including whether the effectiveness of previously successful strategies can be confirmed during a subsequent influenza season.
The 7 groups in the trial
- Usual CareNo study treatment, for comparison
No letter
- Standard LetterTreatment being tested
This group will receive a standard letter on the benefits of influenza vaccination without behavioral economic enhancement
Treatment: Behavioral Economic Principles
- Repeated LetterTreatment being tested
The standard letter sent out two times instead of once
Treatment: Behavioral Economic Principles
- Cardiovascular Gain-Framing LetterTreatment being tested
Text added to the standard letter highlighting potential cardiovascular benefits of influenza vaccination
Treatment: Behavioral Economic Principles
- Respiratory Gain-Framing LetterTreatment being tested
Text added to the standard letter highlighting potential respiratory disease-related benefits of influenza vaccination
Treatment: Behavioral Economic Principles
- Implementation Intention Prompt LetterTreatment being tested
Implementation intention prompt added to the standard letter
Treatment: Behavioral Economic Principles
- Loss-Framing LetterTreatment being tested
Text added to the standard letter highlighting potential risks of not receiving influenza vaccination
Treatment: Behavioral Economic Principles
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Electronic Nudges to Increase Influenza Vaccination in Immunosuppressed Adults Across the Age Spectrum: A Pooled Analysis of 2 Nationwide Randomized Trials.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026
- Electronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction: Insights From 3 Nationwide Randomized Clinical Trials.JAMA cardiology, 2025
- Electronic nudges for sustained influenza vaccination uptake in older adults: the nationwide randomized NUDGE-FLU-2 trial.Nature medicine, 2024
- Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season.American heart journal, 2024
- Record updated
- 10 October 2024